Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000912282-25-000701
Filing Date
2025-06-23
Accepted
2025-06-23 09:38:51
Documents
1
Period of Report
2025-06-13

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3687
  Complete submission text file 0000912282-25-000701.txt   5325
Mailing Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065
Business Address 275 SHORELINE DRIVE, SUITE 500 REDWOOD CITY CA 94065 650-206-4507
Rezolute, Inc. (Issuer) CIK: 0001509261 (see all company filings)

EIN.: 273440894 | State of Incorp.: NV | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 49, BONGEUNSA-RO 49-GIL, GANGNAM-GU SEOUL SOUTH KOREA Korea, Republic of
Business Address
Kim Young-Jin (Reporting) CIK: 0001768406 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39683 | Film No.: 251063251